CorMedix Therapeutics, based in Parsippany, New Jersey, shared news on April 07, 2026, that they will be present at the 25th Annual Needham Virtual Healthcare Conference from April 13 to 16, 2026. The company, traded on Nasdaq as CRMD, specializes in creating and selling therapeutic products for severe diseases. Senior management from CorMedix will engage in a fireside chat and investor discussions during the event. This opportunity at the conference signifies a significant step for the company in advancing its goals and reaching out to potential investors.